Home
News
Create
Screeners
Insights
Transgene Biotek
2.
08
-0.18
(-7.96%)
Market Cap
₹15.74 Cr
PE Ratio
-10.76
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
-7.96%
1M
-26.76%
6M
-54.78%
1Y
-54.49%
5Y
-49.14%
View Company Insights
Latest news about Transgene Biotek
Transgene Biotech Limited Faces SEBI Recovery Proceedings Over Rs.38 Lacs Penalty Default
2 hrs ago
Today
Transgene Biotech Limited has disclosed receiving SEBI's prohibitory order RRD/SRO/1166/2026/1 for recovery of Rs.38 lacs penalty from a June 27, 2022 adjudication order. The order has frozen all bank accounts and prohibited disposal of company assets, causing complete operational paralysis including salary payment suspension. Despite having filed an appeal with Securities Appellate Tribunal on October 7, 2022, which remains pending, the recovery proceedings have brought all business activities to a standstill.
Transgene Biotek Reports Net Loss and Approves Key Board Decisions
Nov 14, 2025
Transgene Biotek Faces Legal Challenge at NCLT Over Rs 6.82 Crore Unpaid Loan
Oct 17, 2025
Transgene Biotek Reports Q1 Loss, Appoints New Auditors Amid Ongoing Regulatory Challenges
Aug 07, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation